Cargando…
肺癌免疫检查点抑制剂的联合治疗研究进展
Immune checkpoint inhibitors (ICIs) therapy is the most commonly used immunotherapy regimen at present. It has been approved for clinical treatment of melanoma, kidney cancer, head and neck cancer, bladder cancer and other tumors. It has made a breakthrough in the treatment of lung cancer and become...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049794/ https://www.ncbi.nlm.nih.gov/pubmed/32093454 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.05 |